Stock ValuationThe stock continues to trade at a discount relative to the P&C sector average, despite delivering EPS growth at twice the industry rate.
Strategic Growth PlansREVO has basically met all the targets of its 2022-25 business plan, with the 2025 target of EUR 300M premiums reached already in 2024 and FY24 adj. operating result and net profit rising to 2.5x and 2.1x the levels of 2022.
Technological AdvancementsTechnology remains a key enabler of REVO’s strong growth trajectory, with the development of OverX and new generative AI-based solutions expected to strengthen the entire insurance value chain.